top of page

 Profile

2006年:慶應義塾大学医学部卒業

2006-2008年:慶應義塾大学病院研修医

2008-2010年:慶應義塾大学精神・神経科専修医

2010-2012年:足利赤十字病院神経精神科・神経内科

2012-2016年:慶應義塾大学大学院医学研究科

2016-2024年:下総精神医療センター、医長

他、

2017-2019年:ロンドン大学セントジョージ校研究留学

2020-現在:慶應義塾大学精神・神経科、現在は特任講師

専門:一般精神科

(医学博士・精神科指定医・専門医・指導医、内科認定医)

所属学会:精神神経学会、内科学会、認知症学会、児童青年精神医学会

​趣味:素人ピアノ、テニス、フットサル、将棋

演奏会時.jpeg

学術論文集 査読付き英文雑誌 1.*Funayama M, Hisamatsu T, Koreki A. Central pontine demyelinolysis following water intoxication in schizophrenia. Schizophr Res. 2011 Feb;125(2-3):300-1 2.Koreki A, Tsunoda K, Suzuki T, Hirano J, Watanabe K, Kashima H, *Uchida H. Clinical and demographic characteristics associated with postural instability in patients with schizophrenia. J Clin Psychopharm 2011;31:16-21. 3.Koreki A, Takahata K, Tabuchi H, *Kato M. Increased left anterior insular and inferior prefrontal activity in post-stroke mania. BMC Neurol. 2012 Aug 6;12:68. 4.*Maeda T, Takahata K, Muramatsu T, Okimura T, Koreki A, Iwashita S, Mimura M, Kato M. Reduced sense of agency in chronic schizophrenia with predominant negative symptoms. Psychiatry Res. 2013 Oct 30;209(3):386-92. 5.*Sado M, Inagaki A, Koreki A, Knapp M, Kissane LA, Mimura M, Yoshimura K. The cost of schizophrenia in Japan. Neuropsychiatr Dis Treat. 2013;9:787-98. 6.*Sado M, Takechi S, Inagaki A, Fujisawa D, Koreki A, Mimura M, Yoshimura K. Cost of anxiety disorders in Japan in 2008: a prevalence-based approach. BMC Psychiatry. 2013 Dec 18;13:338. 7.*Koreki A, Nakagawa A, Abe A, Ikeuchi H, Okubo J, Oguri A, Orimo K, Katayama N, Sato H, Shikimoto R, Nishiyama G, Nogami W, Haki K, Hayashi T, Fukagawa Y, Funaki K, Matsuzawa M, Matsumoto A, Mimura M; Keio Psychiatry Resident Class of 2008. Mental health of Japanese psychiatrists: the relationship among level of occupational stress, satisfaction and depressive symptoms. BMC Res Notes. 2015 Mar 26;8:96. 8.*Koreki A, Maeda T, Fukushima H, Umeda S, Takahata K, Okimura T, Funayama M, Iwashita S, Mimura M, Kato M. Behavioral evidence of delayed prediction signals during agency attribution in patients with schizophrenia. Psychiatry Res. 2015 Nov 30;230(1):78-83. 9.*Uchida T, Kishimoto T, Koreki A, Nakao S, Owada A, Koizumi T, Saito A, Sato M, Sawada S, Matsuzaki R, Petrides G, Mimura M. Predictors of readmission after successful electroconvulsive therapy for depression: a chart review study. Int J Psychiatry Clin Pract. 2016 Nov;20(4):260-4. 10.*Funayama M, Muramatsu T, Koreki A, Kato M, Mimura M, Nakagawa Y. Semantic memory deficits are associated with pica in individuals with acquired brain injury. Behav Brain Res. 2017 Apr 29;329:172-179. 11.*Funayama M, Takata T, Koreki A, Ogino S, Mimura M. Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and Mortality. Psychosom Med. 2018 Mar 8. 80:370-376. 12.*Funayama M, Koreki A, Muramatsu T, Mimura M, Kato M, Abe T. Impairment in judgement of the moral emotion guilt following orbitofrontal cortex damage. J Neuropsychol. 2018 Apr 19. 13.*Funayama M, Takata T, Koreki A. Choking incidents among patients with schizophrenia may be associated with severity illness and higher-dose antipsychotics. Gen Hosp Psychiatry. 2019. 59:73-75. 14.*Funayama M, Mizushima J, Takata T, Koreki A, Mimura M. Altered perception might be a symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Neurocase. 2018 Oct - Dec;24(5-6):255-258. 15.*Koreki A, Maeda T, Okimura T, Terasawa Y, Kikuchi T, Umeda S, Nishikata S, Yagihashi T, Kasahara M, Nagai C, Moriyama Y, Den R, Watanabe T, Kikumoto H, Kato M, Mimura M. Dysconnectivity of the Agency Network in Schizophrenia: A Functional Magnetic Resonance Imaging Study. Front Psychiatry. 2019 Apr 3;10:171. 16.*Kurose S, Koreki A, Funayama M, Takahashi E, Kaji M, Ogyu K, Takasu S, Koizumi T, Suzuki H, Onaya M, Mimura M. Resting-state hyperperfusion in the whole brain: A case of malignant catatonia that improved with electric convulsion therapy. Schizophr Res. 2019 210:287-288. 17.Teodoro T, Koreki A, Meppelink AM, Little S, Nielsen G, Macerollo A, Ferreira JJ, Pareés I, Lang A, *Edwards MJ. Contingent negative variation: a biomarker of abnormal attention in Functional Movement Disorders. Eur J Neurol. 2020 27(6):985-994. 18.*Funayama M, Koreki A, Takata T, Kurose S. Catatonia, bedridden status, choking, water intoxication, and suicide are involved in deaths of schizophrenia inpatients. Asian J Psychiatr. 2020 Apr 8;51:102054. 19.Koreki A, Garfkinel SN, Mula M, Agrawal N, Cop S, Eilon T, Gould van Praag CD, Critchley HD, Edwards M, *Yogarajah M. Trait and state interoceptive abnormalities are associated with dissociation and seizure frequency in patients with functional seizures. Epilepsia. 61(6):1156-1165, 2020. 20.*Koreki A, Nakane J, Kitada S, Hamaya T, Ishii H, Akimoto K, Aso K, Onaya M. Impact of COVID-19 on psychiatric day care services. Asian J Psychiatr. 2020 Dec;54:102442. 21.*Funayama M, Mimura Y, Takata T, Koreki A, Ogino S, Kurose S. Body mass index and blood urea nitrogen to creatinine ratio predicts refeeding hypophosphatemia of anorexia nervosa patients with severe malnutrition. J Eat Disord. 2021 Jan 6;9(1):1 22.*Koreki A, Funayama M, Terasawa Y, Onaya M, Mimura M. Aberrant Interoceptive Accuracy in Patients With Schizophrenia Performing a Heartbeat Counting Task, Schizophrenia Bulletin Open, Volume 2, Issue 1, January 2021, sgaa067, https://doi.org/10.1093/schizbullopen/sgaa067 23.Koreki A, *Sado M, Katayama N, Rutherford A, Bowes A. Is 'dementia-friendly design' cost effective? The results of a preliminary literature review. Psychogeriatrics. 2021 Apr 20 24.*Koreki A, Mori H, Nozaki S, Koizumi T, Suzuki H, Onaya M. Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs: A Cross-sectional Study.J Clin Psychopharmacol. 2021 Jul-Aug 01;41(4):474-477. 25.*Funayama M, Mimura Y, Takata T, Koreki A, Ogino S, Kurose S, Shimizu Y. Hypokalemia in patients with anorexia nervosa during refeeding is associated with binge-purge behavior, lower body mass index, and hypoalbuminemia. J Eat Disord. 2021 Aug 6;9(1):95. 26.*Koreki A, Koizumi T, Ogyu K, Onaya M. Case Report: Culture-Dependent Postures in Japanese Patients With Schizophrenia. Front Psychiatry. 2021 Aug 5;12:686817. 27.*Sado M, Koreki A, Ninomiya A, Kurata C, Mitsuda D, Sato Y, Kikuchi T, Fujisawa D, Ono Y, Mimura M, Nakagawa A. Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings. Psychiatry Clin Neurosci. 2021 Aug 29. 28.*Koreki A, Kusudo K, Suzuki H, Nozaki S, Onaya M, Bowes A, Sado M. Are Analogue or Digital Clocks Friendlier for People Living with Dementia? Dement Geriatr Cogn Disord Extra 2021;11:207–212. 29.*Sado M, Ninomiya A, Nagaoka M, Koreki A, Goto N, Sasaki Y, Takamori C, Kosugi T, Yamada M, Park S, Sato Y, Fujisawa D, Nakagawa A, Mimura M. Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2022 Jan 21;11(1):e33776. doi: 10.2196/33776. 30.*Koreki A, Niida R, Niida A, Yamagata B, Anamizu S, Mimura M. Comparison of White Matter Structure of Drug-Naïve Patients With Bipolar Disorder and Major Depressive Disorder Using Diffusion Tensor Tractography. Front Psychiatry. 2022 Feb 14;12:714502. 31.Sado M, Ninomiya A, Nagaoka M, Koreki A, Goto N, Sasaki Y, Takamori C, Kosugi T, Yamada M, Park S, Sato Y, Fujisawa D, Nakagawa A, Mimura M. Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2022 Jan 21;11(1):e33776. 32.Sado M, Yamada M, Ninomiya A, Nagaoka M, Goto N, Koreki A, Nakagawa A, Segal Z, Mimura M. Effectiveness and cost-effectiveness of online brief Mindfulness-Based Cognitive Therapy for the improvement of productivity in the workplace: Study protocol for a randomized controlled trial. JMIR Res Protoc. 2022 Apr 2. 33.*Funayama M, Koreki A, Mimura Y, Takata T, Ogino S, Kurose S, Shimizu Y, Kudo S. Restrictive type and infectious complications might predict nadir hematological values among individuals with anorexia nervosa during the refeeding period: a retrospective study. J Eat Disord. 2022 May 5;10(1):64. 34.*Koreki A, Koizumi T, Ogyu K, Mashima Y, Taguchi K, Onaya M. Mask-Induced Ear Injury in Schizophrenia: A Novel Complication in the COVID-19 Era. Psychiatry Clin Neurosci. 2022 May 11. 35.Koreki A, Eccles J, Garfinkel S, Critchley H, Cope S, Agrawal N, Edwards M, *Yogarajah M. Hypermobility in patients with functional seizures: Toward a pathobiological understanding of complex conditions. Epilepsy Behav. 2022 May 14;132:108710. 36.*Funayama M, Koreki A, Takata T, Kurose S, Hisamatsu T, Ono A, Yagihashi T, Mizushima J, Yagi Y, Ogino S, Oi H, Mimura Y, Shimizu Y, Kudo S, Nishi A, Mukai H. Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis. J Psychiatr Res. 2022 May 13;151:419-426. 37.Mashima Y, Koizumi T, Minegishi S, Miyakoshi M, Okada M, Ogyu K, Kusudo K, Kiyohara M, Kitada S, Koyanagi K, Suzuki H, Nozaki S, Oda A, Hirai S, Nakane J, Onaya M, Oda T, *Koreki A. Impact of the COVID-19 pandemic on patients with mental health problems and the differences among diagnostic categories. Int J Soc Psychiatry. 2022 Jun 2:207640221097509. 38.*Takeda T, Kokubun S, Saito Y, Tsuneyama A, Ishikawa A, Isose S, Ito K, Arai K, Koreki A, Sugiyama A, Kuwabara S, Honda K. Progressive medial temporal degeneration with TDP-43 pathology is associated with upper limb and bulbar onset types of amyotrophic lateral sclerosis. J Neurol. 2022 Jun 16. 39.Koreki A, Goeta D, Ricciardi L, Eilon T, Chen J, Critchley HD, Garfinkel SN, Edwards M, *Yogarajah M. The relationship between interoception and agency and its modulation by heartbeats: an exploratory study. Sci Rep. 2022 Aug 10;12(1):13624. 40.Teodoro T, Koreki A, Chen J, Coebergh J, Poole N, Ferreira JJ, Edwards MJ, Isaacs JD. Functional cognitive disorder affects reaction time, subjective mental effort and global metacognition. Brain. 2022 Oct 6:awac363. 41.Koreki A, Nagaoka M, Ninomiya A, Mimura M, Sado M. Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales. Psychol Res Behav Manag. 2022 Nov 4;15:3233-3241. 42.Ogyu K, Matsushita K, Honda S, Wada M, Tamura S, Takenouchi K, Tobari Y, Kusudo K, Kato H, Koizumi T, Arai N, Koreki A, Matsui M, Uchida H, Fujii S, Onaya M, Hirano Y, Mimura M, Nakajima S, *Noda Y. Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia. Schizophr Res. 2023 Feb;252:129-137. doi: 10.1016/j.schres.2023.01.011. 43.Elkommos S, Martin-Lopez D, Koreki A, Jolliffe C, Kandasamy R, Mula M, Critchley HD, Edwards MJ, Garfinkel S, Richardson MP, Yogarajah M. Changes in the heartbeat-evoked potential are associated with functional seizures. J Neurol Neurosurg Psychiatry. 2023 May 25:jnnp-2022-330167. doi: 10.1136/jnnp-2022-330167. 44.*Koreki, A, Mashima, Y, Oda, A, Koizumi, T, Koyanagi, K, Onaya, M. You are already dead: case report of nihilistic delusions regarding others as one representation of Cotard's syndrome. Psychiatry Clin Neurosci Rep. 2023; 2:e93. https://doi.org/10.1002/pcn5.93 45.*Funayama M, Koreki A, Takata T, Hisamatsu T, Mizushima J, Ogino S, Kurose S, Oi H, Mimura Y, Shimizu Y, Kudo S, Nishi A, Mukai H, Wakisaka R, Nakano M. Pneumonia Risk Increased by Dementia-Related Daily Living Difficulties: Poor Oral Hygiene and Dysphagia as Contributing Factors. Am J Geriatr Psychiatry. 2023 May 22:S1064-7481(23)00298-1. doi: 10.1016/j.jagp.2023.05.007. 46.Nagaoka M, Koreki A, Kosugi T, Ninomiya A, Mimura M, *Sado M. Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults. Psychol Res Behav Manag. 2023 Jul 20;16:2767-2785. doi: 10.2147/PRBM.S406347. 47.*Koreki A, Kurose S, Kaji M, Mashima Y, Iwamura K, Okada M, Hayasaka T, Oda A, Nakane J, Onaya M. Psychotic self-renaming and its unique features: A case series. Psychiatry Research Case Reports. 2 (2), 2023. doi.org/10.1016/j.psycr.2023.100140 48.Nakano M, Funayama M, Wakisaka R, Takata T, Kudo S, Kuramochi S, Koreki A, Ogino S, Ishida T, Uchida H, Mimura M. Caution to psychiatry ward: COVID-19 pneumonia can manifest weeks or months after testing positive with a PCR test in individuals on preexisting immune-suppressing medication. Psychiatry Clin Neurosci Rep. 2023; 2:e135. https://doi.org/10.1002/pcn5.135 49.Koreki A, Garfinkel S, Critchley H, Cope S, Agrawal N, Edwards M, *Yogarajah M. Impaired cardiac modulation in patients with functional seizures: Results from a face intensity judgment task. Epilepsia. 2023 Aug 23. doi: 10.1111/epi.17761. 50.Sone D, Young A, Shinagawa S, Tsugawa S, Iwata Y, Tarumi R, Ogyu K, Honda S, Ochi R, Matsushita K, Ueno F, Hondo N, Koreki A, Torres-Carmona E, Mar W, Chan N, Koizumi T, Kato H, Kusudo K, de Luca V, Gerretsen P, Remington G, Onaya M, Noda Y, Uchida H, Mimura M, Shigeta M, Graff-Guerrero A, Nakajima S. Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance. Schizophr Bull. 2023 Nov 25:sbad164. doi: 10.1093/schbul/sbad164. 51.Miyakoshi M, Arai T, Kurose S, Kaji M, Nakane J, Onaya M, *Koreki A. Spontaneous Bladder Rupture in a Catatonic Schizophrenia Patient. Case Rep Psychiatry. 2023 Nov 21;2023:4277372. doi: 10.1155/2023/4277372. 52.Koreki A, Ogyu K, Miyazaki T, Takenouchi K, Matsushita K, Honda S, Koizumi T, Onaya M, Uchida H, Mimura M, *Nakajima S, *Noda Y. Aberrant heartbeat-evoked potential in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Feb 16;132:110969. doi: 10.1016/j.pnpbp.2024.110969. 53.Funayama M, Hojo T, Nakagawa Y, Kurose S, Koreki A. Investigating the Link Between Subjective Depth Perception Deficits and Objective Stereoscopic Vision Deficits in Individuals With Acquired Brain Injury. Cogn Behav Neurol. 2024 Apr 29. doi: 10.1097/WNN.0000000000000369. 54.Nakano M, Funayama M, Takata T, Wakisaka R, Koyama G, Koreki A, Ishida T, Uchida H, Mimura M. Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy. BMC Psychiatry. 2024 Jun 4;24(1):411. doi: 10.1186/s12888-024-05846-5. 55.Nakano M, Funayama M, Wakisaka R, Takata T, Kudo S, Kuramochi S, Koreki A, Ogino S, Ishida T, Uchida H, Mimura M. Caution to psychiatry ward: COVID-19 pneumonia can manifest weeks or months after testing positive with a PCR test in individuals on preexisting immune-suppressing medication. PCN Rep. 2023 Aug 27;2(3):e135. doi: 10.1002/pcn5.135. 56.Funayama M, Koreki A, Takata T, Nakagawa Y, Mimura M. Post-stroke urinary incontinence is associated with behavior control deficits and overactive bladder. Neuropsychologia. 2024 Aug 13;201:108942. doi: 10.1016/j.neuropsychologia.2024.108942.

お問い合わせ

American Wellness Center

Ground Floor, Building 39 Dubai Healthcare City

+971 55 918 9701 (American Wellness Center, 日本語受付, WhatsAPPメッセージ可)

jp.info@americanwellnesscenter.ae

診療日は基本的に月曜から木曜、土曜の9:00~17:00ですが、それ以外の時間帯に対応可能な場合や、休診となる日もございますので、お気軽にお問い合わせください。

bottom of page